Lybrel-Birth-Control.com

wyeth.gif

Summary: Wyeth (NYSE: WYE ) and Solvay Pharmaceutical B.V. have previously entered into co-development and co-commercialization agreements for bifeprunox and other neuroscience compounds. The said old collaboration has already resulted to a New Drug Application (NDA) submitted on October 11, 2006 to the USFDA for bifeprunox for the treatment schizophrenic patients while

Image Dimensions: 235 x 167